Author

D. Castillo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:fungi (other)· 1 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Bustamante· 1 shared B. Cabanillas· 1 shared B. G. Murphy· 1 shared C. Dufloer· 1 shared D. Alvarez· 1 shared D. Dorhout· 1 shared D. X. Sahonero Canavesi· 1 shared E. Hopmans· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Bustamante

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Unraveling an unknown diversity of archaeal and bacterial tetraether membrane lipid producers in a euxinic marine system

D. Castillo, F. A. B. von Meijenfeldt, D. X. Sahonero Canavesi, D. Dorhout, N. Bale, E. Hopmans, L. Villanueva

The paper identifies potential microbial producers of branched GDGTs in anoxic marine environments using lipid analysis and metagenomic data.

bioRxiv · Jun 25, 2024 · PreprintMicrobiology

A rational approach to identifying effective combined anticoronaviral therapies against feline coronavirus

S.E. Cook, H. Vogel, D. Castillo, M. Olsen, N. Pedersen, B. G. Murphy

The paper screens 89 compounds for antiviral activity against feline infectious peritonitis virus (FIPV) and identifies synergistic drug combinations with potential for treating coronaviruses like SARS-CoV-2.

bioRxiv · Jul 9, 2020 · PreprintPharmacology & Toxicology

Bioactive compounds from Chrysosporium multifidum, a fungus isolated from Hermetia illucens gut microbiota

B. Cabanillas, Y. Correa, V. Jullian, D. Alvarez, D. Castillo, C. Dufloer, B. Bustamante, E. Roncal, E. Neyra, P. Sheen, M. Sauvain

This study isolates and identifies Chrysosporium multifidum from Hermetia illucens gut microbiota and characterizes six pyrone derivatives and one diketopiperazine with antimicrobial activity against MRSA.

bioRxiv · Jun 12, 2019Microbiology